1. Home
  2. COSM vs CLGN Comparison

COSM vs CLGN Comparison

Compare COSM & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cosmos Health Inc.

COSM

Cosmos Health Inc.

HOLD

Current Price

$0.50

Market Cap

18.9M

Sector

Health Care

ML Signal

HOLD

Logo CollPlant Biotechnologies Ltd

CLGN

CollPlant Biotechnologies Ltd

HOLD

Current Price

$1.91

Market Cap

18.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COSM
CLGN
Founded
2009
2004
Country
United States
Israel
Employees
N/A
N/A
Industry
Other Pharmaceuticals
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.9M
18.4M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
COSM
CLGN
Price
$0.50
$1.91
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$11.50
AVG Volume (30 Days)
1.3M
31.5K
Earning Date
11-17-2025
11-26-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$59,792,819.00
$2,475,000.00
Revenue This Year
$20.69
$1,596.12
Revenue Next Year
$53.10
$85.83
P/E Ratio
N/A
N/A
Revenue Growth
6.69
280.77
52 Week Low
$0.28
$1.30
52 Week High
$1.32
$4.98

Technical Indicators

Market Signals
Indicator
COSM
CLGN
Relative Strength Index (RSI) 49.03 64.69
Support Level $0.47 $1.40
Resistance Level $0.53 $1.99
Average True Range (ATR) 0.06 0.15
MACD 0.00 0.07
Stochastic Oscillator 55.69 93.22

Price Performance

Historical Comparison
COSM
CLGN

About COSM Cosmos Health Inc.

Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.

About CLGN CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.

Share on Social Networks: